NCT06173349View on ClinicalTrials.gov

PLZ4-Coated Paclitaxel-Loaded Micelles for the Treatment of Patients With Recurrent or Refractory Non-Muscle Invasive Bladder Cancer

PHASE1RecruitingINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 22, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

June 30, 2026

Conditions
Recurrent Non-Muscle Invasive Bladder CarcinomaStage 0a Bladder Cancer AJCC v8Stage 0is Bladder Cancer AJCC v8Stage I Bladder Cancer AJCC v8
Interventions
DRUG

PLZ4-coated paclitaxel loaded micelles (PPM)

Given PLZ4-coated paclitaxel loaded micelles intravesically

Trial Locations (1)

95817

RECRUITING

University of California Davis Comprehensive Cancer Center, Sacramento

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Mamta Parikh

OTHER